title: The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs.
abstract: The in vivo flux rates of glucose (6-3H-glucose) and of alanine (U-14C-alanine) were measured in insulin-dependent chronically diabetic dogs which were infused with insulin employing a bedside-type artificial B cell and either the peripheral or the portal venous route. In comparison with non-diabetic control animals the diabetic dogs had near-normal patterns of glucose metabolism and pancreatic glucagon regardless of the route of insulin administration. They also showed reduced basal portal but moderately elevated peripheral insulin levels on peripheral and near-normal peripheral values on portal insulin infusion. Both concentration and production rates of alanine were reduced on peripheral (0.142 +/- 0.016 mmol/l, 4.73 +/- 0.49 mumol.kg-1.min-1, p less than 0.05) but normal on portal insulin (0.206 +/- 0.030 mmol/l, 6.33 +/- 0.63 mumol.kg-1.min-1). The alanine clearance was slightly elevated or normal in the diabetic dogs, and the glucose production from alanine showed a strongly delayed response to an exogenous glucose load on either route of insulin administration. It is concluded that the peripheral hyperinsulinism during posthepatic insulin administration stimulates glucose utilisation to a normal extent, but inhibits the provision of amino groups in resting muscle. Alanine synthesis is thereby reduced, and the carbon moieties are shunted from glucose into circulating lactate. Long-term studies are needed to elucidate the role of the liver under these conditions.
authors.affiliation: Central Institute of Diabetes Gerhardt Katsch, Karlsburg, GDR.
authors.forename: E J
authors.initials: EJ
authors.lastname: Freyse
authors.forename: U
authors.initials: U
authors.lastname: Fischer
authors.forename: G
authors.initials: G
authors.lastname: Albrecht
authors.forename: S
authors.initials: S
authors.lastname: Marx
authors.forename: H
authors.initials: H
authors.lastname: Keilacker
mesh_terms: D000409:Alanine / Q000097:blood*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood* / Q000188:drug therapy; D004285:Dogs; D007328:Insulin / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D007700:Kinetics; D011168:Portal System; D011172:Portography
chemical_list: D001786:Blood Glucose; D007328:Insulin; D000409:Alanine